Related Experiment Video
Updated: Apr 16, 2026

Author Spotlight: Exploring the Role of Unfolded Protein Response in HIV-1 Replication and Infectivity
Published on: June 14, 2024
Targeting unfolded protein response in cancer and diabetes
1Section of PharmacogeneticsDepartment of Physiology and Pharmacology, Karolinska Institutet, 17177 Stockholm, Sweden souren.mkrtchian@ki.se.
Abstract:
The maturation of secretory and membrane proteins in the endoplasmic reticulum (ER) is tightly regulated by the unfolded protein response (UPR), a signal transduction pathway maintaining ER protein folding homeostasis. However, certain ER states are incompatible with cell survival and therefore the UPR may choose to eliminate severely disrupted cells by apoptosis. This is accomplished primarily through the activation of the transcription factor CCAAT-enhancer-binding protein homologous protein (CHOP). In the April 2015 issue of Endocrine-Related Cancer, researchers from the universities of South Carolina and Athens (Greece) suggested a novel mechanism of CHOP-mediated apoptosis connected with the suppression of a prominent cell cycle regulator with anti-apoptotic activity, p21. These findings and suggested clinical applications, such as potentiation of cancer chemotherapy and a novel therapeutic approach for type 2 diabetes, are discussed in the context of UPR.
Related Concept Videos
Regulation of the Unfolded Protein Response
The Unfolded Protein Response
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Psychoneuroimmunology: Diabetes and Cancer
Insulin: The Receptor and Signaling Pathways

